Holen Sie sich die Stockscreener-App
19.79
0.94%
0.19
Schlusskurs vom Vortag:
$19.60
Offen:
$19.46
24-Stunden-Volumen:
2.07M
Relative Volume:
0.23
Marktkapitalisierung:
$13.65B
Einnahmen:
$2.87B
Nettoeinkommen (Verlust:
$250.10M
KGV:
62.08
EPS:
0.3188
Netto-Cashflow:
$1.13B
1W Leistung:
+3.32%
1M Leistung:
+19.84%
6M Leistung:
+16.25%
1J Leistung:
+15.84%
1-Tages-Spanne:
$19.45
$19.82
1-Wochen-Bereich:
$18.90
$19.82
52-Wochen-Spanne:
$15.70
$20.27
Healthpeak Properties Inc Stock (DOC) Company Profile
Firmenname
Healthpeak Properties Inc
Sektor
Telefon
949-407-0700
Adresse
4600 SOUTH SYRACUSE STREET, DENVER, WI
Compare DOC vs WELL, VTR, OHI, AHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DOC
Healthpeak Properties Inc
|
19.80 | 13.51B | 2.87B | 250.10M | 1.13B | 0.3188 |
WELL
Welltower Inc
|
210.16 | 141.78B | 11.75B | 1.46B | 2.19B | -0.6014 |
VTR
Ventas Inc
|
82.66 | 38.46B | 6.13B | 272.21M | 1.38B | 0.5521 |
OHI
Omega Healthcare Investors Inc
|
45.09 | 13.01B | 1.24B | 655.98M | 857.80M | 2.063 |
AHR
American Healthcare Reit Inc
|
47.72 | 9.59B | 2.27B | 70.82M | 165.88M | 0.4079 |
Healthpeak Properties Inc Stock (DOC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-20 | Eingeleitet | UBS | Neutral |
| 2026-02-05 | Herabstufung | Argus | Buy → Hold |
| 2026-01-09 | Eingeleitet | Goldman | Neutral |
| 2025-12-16 | Herabstufung | Jefferies | Buy → Hold |
| 2025-10-01 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2025-09-15 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2025-08-20 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-07-29 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2025-01-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-10-21 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-05-03 | Hochstufung | Wedbush | Neutral → Outperform |
| 2024-04-26 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2024-04-22 | Fortgesetzt | Mizuho | Buy |
| 2024-04-01 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-03-25 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2024-03-08 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2024-01-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-26 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-04-20 | Eingeleitet | Wells Fargo | Underweight |
| 2022-12-14 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2022-10-28 | Eingeleitet | JP Morgan | Neutral |
| 2022-08-05 | Herabstufung | Colliers Securities | Buy → Neutral |
| 2022-06-03 | Eingeleitet | CapitalOne | Equal Weight |
| 2022-05-19 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-04-26 | Eingeleitet | Barclays | Overweight |
| 2022-02-01 | Eingeleitet | Credit Suisse | Neutral |
| 2022-01-07 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2021-09-13 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-08-20 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2021-06-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2021-03-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-01-13 | Hochstufung | Jefferies | Hold → Buy |
| 2020-12-14 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-11-11 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-09-30 | Fortgesetzt | Robert W. Baird | Outperform |
| 2020-09-02 | Fortgesetzt | Stifel | Buy |
| 2020-04-07 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-04-01 | Hochstufung | Berenberg | Hold → Buy |
| 2020-03-16 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-03-09 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2020-02-27 | Hochstufung | CapitalOne | Equal Weight → Overweight |
| 2019-12-20 | Eingeleitet | Mizuho | Buy |
| 2019-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-11-26 | Hochstufung | Stifel | Hold → Buy |
| 2019-10-14 | Eingeleitet | BofA/Merrill | Neutral |
| 2019-06-20 | Eingeleitet | Citigroup | Neutral |
| 2019-05-02 | Herabstufung | CapitalOne | Overweight → Equal Weight |
| 2018-08-03 | Hochstufung | CapitalOne | Equal Weight → Overweight |
| 2018-04-25 | Herabstufung | Stifel | Buy → Hold |
| 2018-03-01 | Bestätigt | B. Riley FBR, Inc. | Buy |
| 2018-01-05 | Bestätigt | Robert W. Baird | Outperform |
| 2017-11-06 | Hochstufung | Hilliard Lyons | Long-term Buy → Buy |
Alle ansehen
Healthpeak Properties Inc Aktie (DOC) Neueste Nachrichten
Earnings call transcript: Healthpeak Properties’ Q1 2026 earnings soar, stock surges - Investing.com
Healthpeak Properties Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Healthpeak (DOC) Down 2.2% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Healthpeak Properties Inc. stock outperforms competitors despite losses on the day - MarketWatch
HCP Changes Name to Healthpeak Properties - Nareit
[Form 4] HEALTHPEAK PROPERTIES, INC. Insider Trading Activity - Stock Titan
HEALTHPEAK PROPERTIES (DOC) EVP acquires ESPP shares, forfeits some for taxes - Stock Titan
HEALTHPEAK PROPERTIES (NYSE: DOC) CFO boosts stake with ESPP share purchase - Stock Titan
Healthpeak Properties (DOC) CIO adds ESPP shares, small tax forfeiture - Stock Titan
Healthpeak Properties (NYSE: DOC) EVP adds ESPP shares, forfeits some for taxes - Stock Titan
Healthpeak (DOC) CEO adds ESPP shares, small tax withholding - Stock Titan
Healthpeak Properties Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Healthpeak Properties stock: Is DOC underperforming the real estate sector? - MSN
DOC Maintains by Wells Fargo -- Price Target Raised to $20.00 - GuruFocus
Wells Fargo Adjusts PT on Healthpeak Properties to $20 From $18, Maintains Equalweight Rating - marketscreener.com
The Best REITs to Buy - Morningstar
Healthpeak Properties Inc. stock underperforms Friday when compared to competitors - MarketWatch
DOC Q1 2026 Earnings: EPS Surprises 515% Above Estimates, Stock Slips Amid Revenue DiscrepanciesProfit Margin Analysis - newsline.com
Morgan Stanley Adjusts Price Target on Healthpeak Properties to $20 From $18, Maintains Overweight Rating - Moomoo
What's in the cards for Healthpeak Properties this earnings season? - MSN
Healthpeak Properties Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Healthpeak Properties, Inc. Hits New 52-Week High at USD 20.27 - Markets Mojo
Scotiabank Maintains Healthpeak Properties(DOC.US) With Hold Rating, Raises Target Price to $21 - Moomoo
Scotiabank Adjusts PT on Healthpeak Properties to $21 From $19, Maintains Sector Perform Rating - Moomoo
DOC Maintained by Scotiabank -- Price Target Raised to $21.00 - GuruFocus
Is It Time To Reassess Healthpeak Properties (DOC) After Its Strong Recent Share Price Run - Sahm
Healthpeak Properties stock reaches 52-week high at 19.94 USD By Investing.com - Investing.com India
Healthpeak Properties Inc. stock outperforms competitors on strong trading day - MarketWatch
Healthpeak Properties stock reaches 52-week high at 19.94 USD - Investing.com
Healthpeak Properties Gains 22.7% Year to Date: Will the Trend Last? - The Globe and Mail
Healthpeak Properties (DOC) Gains Momentum with Positive Market Trends - GuruFocus
Morgan Stanley Maintains Healthpeak Properties(DOC.US) With Buy Rating, Raises Target Price to $20 - Moomoo
Healthpeak Properties Is Maintained at Overweight by Morgan Stanley - Moomoo
Healthpeak Properties Price Target Raised to $20.00/Share From $18.00 by Morgan Stanley - Moomoo
DOC Maintained by Morgan Stanley -- Price Target Raised to $20 - GuruFocus
What is Janus Living and Why is Healthpeak Spinning it Off - Kavout
A Look At Healthpeak Properties (DOC) Valuation After Strong Recent Share Price Momentum - Yahoo Finance
Healthpeak Properties Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Healthpeak’s S&P 500 Rally Raises A Big Valuation Question - Kalkine Media
Analysts Offer Insights on Real Estate Companies: Rayonier (RYN), Weyerhaeuser (WY) and Healthpeak Properties (DOC) - The Globe and Mail
Assessing Healthpeak Properties (DOC) Valuation After Recent Share Price Momentum - simplywall.st
Verizon and 4 More Stocks With 5% Dividend Yields—and Market-Beating Returns - Barron's
Mizuho Securities Maintains Healthpeak Properties(DOC.US) With Buy Rating, Raises Target Price to $21 - Moomoo
New York Life Investment Management LLC Boosts Holdings in Healthpeak Properties, Inc. $DOC - MarketBeat
Healthpeak (DOC) CEO makes 120,372-unit OP equity gifts, retains stake - Stock Titan
How Investors Are Reacting To Healthpeak Properties (DOC) Earnings Upgrade And Completed Share Buyback - simplywall.st
Are Wall Street analysts bullish on Healthpeak Properties stock? - MSN
Verizon and 4 Other Stocks With 5% Yields—and Market-Beating Returns - Barron's
Baird Raises its Price Target on Healthpeak Properties (DOC) - Insider Monkey
Mizuho Adjusts Price Target on Healthpeak Properties to $21 From $18, Maintains Outperform Rating - Moomoo
Finanzdaten der Healthpeak Properties Inc-Aktie (DOC)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):